Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Risk factors associated with urinary albumin excretion in African Americans

Abstract

Microalbuminuria is considered a marker of heightened risk for cardiovascular events. We examined cardiovascular risk factors, including inflammatory cytokines, which contribute to urinary albumin excretion (UAE) in a cross-sectional study of African Americans aged 18–49 years. Measurements included a timed overnight urine collection for UAE, blood pressure (BP), body mass index, glucose, lipids, insulin and inflammatory cytokines. Non-normally distributed variables were log transformed for analysis using multiple linear regressions. Data were obtained from 488 participants with mean age 37.8 years; 50% were obese, 42% had hypertension. Log UAE correlated significantly with systolic BP (SBP) (geometric mean ratio=1.011; 95% confidence interval 1.003–1.019). When subjects were stratified into four UAE groups, the only variables significantly different between groups were SBP (P=0.013) and diastolic BP (P=0.036). There were no statistically significant associations with obesity, metabolic parameters, insulin resistance or any inflammatory cytokines identified. In young, relatively healthy, African Americans, BP level is significantly associated with levels of UAE even below the threshold for microalbuminuria. The presence of diabetes and insulin resistance in the absence of high BP did not seem to contribute significantly to UAE in this cohort.

This is a preview of subscription content, access via your institution

Access options

Similar content being viewed by others

References

  1. Gerstein H, Mann F, Yi Q, Zinman B, Dineen S, Hoogwerf B et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and non-diabetic individuals. JAMA 2001; 286: 421–426.

    Article  CAS  PubMed  Google Scholar 

  2. Wachtel K, Ibsen H, Olsen M, Borch-Johnson K, Lindholm L, Mogensen C et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Annals Int Med 2003; 139: 901–906.

    Article  Google Scholar 

  3. de Zeeuw D, Remuzzi E, Parving H, Keane W, Zhang Z, Shahinfar S et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 2004; 65: 2309–2320.

    Article  CAS  PubMed  Google Scholar 

  4. Forman J, Brenner B . Hypertension and microalbuminuria: The bell tolls for thee. Kidney Int 2006; 69: 22–228.

    Article  CAS  PubMed  Google Scholar 

  5. Coresh J, Selvin E, Stevens L, Manzi J, Kusek J, Eggers P et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038–2047.

    Article  CAS  PubMed  Google Scholar 

  6. Ferris M, Hogan S, Hyunsook C, Shoham D, Gipson D, Gibson K et al. Obesity, albuminuria, and urinalysis findings in US young adults from the Add Health Wave III study. Clin J Am Soc Nephrol 2007; 2: 1207–1214.

    Article  PubMed  Google Scholar 

  7. Hillege H, Fidler V, Diercks G, van Gilst W, deZeeuw D, vanVeldhuisen D, et al., for the Prevention of Renal and Vascular End Stage Disease (PREVEND) study group. Urinary albumin excretion predicts cardiovascular and non-cardiovascular mortality in the general population. Circulation 2002; 106: 1777–1782.

    Article  CAS  PubMed  Google Scholar 

  8. Ninomiya T, Perkovic V, Galan B, Zoungas S, Pillai A, Jardine M et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 2009; 20: 1813–1821.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Wang T, Evans J, Meigs J, Rifai N, Fox C, D’Agostino B et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005; 111: 1370–1376.

    Article  CAS  PubMed  Google Scholar 

  10. Redon J, Morales-Olivas F, Galgo A, Brito M, Mediavilla J, Marin R et al. Urinary albumin excretion and glomerular filtration rate across the spectrum of glucose abnormalities. J Am Soc Nephrol 2006; 17: S236–S245.

    Article  CAS  PubMed  Google Scholar 

  11. Cerasola G, Mule G, Cottone S, Nardi E, Cusimano P . Hypertension, microalbuminuria and renal dysfunction: the Renal Dysfunction in Hypertension (REDHY) study. J Nephrol 2008; 21: 368–373.

    CAS  PubMed  Google Scholar 

  12. Rodila E, Perez-Lahiguera F, Costa J, Gonzalez C, Miralles A, Moral D et al. Association between serum uric acid, metabolic syndrome and microalbuminuria in previously untreated essential hypertensive patients. Med Clin (Barc) 2009; 132: 1–6.

    Article  Google Scholar 

  13. DeCosmo S, Minenna A, Ludorico O, Mastroroianno S, DiGiorgio A, Pirro L et al. Increased Urinary Albumin Excretion, Insulin Resistance, and Related Cardiovascular Risk Factors in Patients With Type 2 Diabetes: Evidence of a sex-specific association. Diabetes Care 2005; 28: 910–915.

    Article  CAS  Google Scholar 

  14. Festa A, D’agostino R, Howard G, Mykkänen L, Tracy R, Haffner S . Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 2000; 58: 1703–1710.

    Article  CAS  PubMed  Google Scholar 

  15. Kario K, Matsuo T, Kobayashi H, Matsuo M, Sakata T, Miyata T et al. Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria. Arterioscler Thromb Vasc Biol 1996; 16: 455–461.

    Article  CAS  PubMed  Google Scholar 

  16. Cottone S, Mulè G, Nardi E, Lorito M, Guarneri M, Arsena R et al. Microalbuminuria and early endothelial activation in essential hypertension. J Hum Hypertens 2007; 21: 167–172.

    Article  CAS  PubMed  Google Scholar 

  17. Stehouwer C, Henry R, Dekker J, Nijpels G, Heine R, Bouter L . Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction—The Hoorn Study. Kidney Int 2004; 66: S42–S44.

    Article  Google Scholar 

  18. Knudsen S, Jeppesen P, Frederiksen C, Andersen T, Bek J, Ingerslev J et al. Endothelial dysfunction, ambulatory pulse pressure, and albuminuria are associated in Type 2 diabetic subjects. Diabetic Med 2007; 24: 911–915.

    Article  CAS  PubMed  Google Scholar 

  19. Ishimura E, Taniwaki H, Obatake N, Emoto M, Shoji T, Inaba M et al. Urinary albumin excretion associated with arterial wall stiffness rather than thickness in type 2 diabetic patients. J Nephrology 2007; 20: 204–211.

    Google Scholar 

  20. Upadhyaya A, Hwang S, Mitchell G, Vasan R, Vita J, Stantchev P et al. Arterial stiffness in mild-moderate CKD. J Am Soc Nephrol 2009; 20: 2044–2053.

    Article  Google Scholar 

  21. Mathews D, Hosker J, Rudenski A, Naylor B, Treavher D, Turner R . Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin correlations in man. Diabetologia 1985; 28: 412–419.

    Article  Google Scholar 

  22. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 2001; 285: 2486–2497.

    Article  Google Scholar 

  23. Mickey R, Greenland S . The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989; 129: 125–137.

    Article  CAS  PubMed  Google Scholar 

  24. Gerber L, Smuckler C, Alderman M . Differences in urinary albumin excretion rate between normotensive and hypertensive, white and non-white subjects. Arch Intern Med 1992; 152: 373–377.

    Article  CAS  PubMed  Google Scholar 

  25. Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo Jr J et al. The National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint Commission on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–1252.

    Article  CAS  PubMed  Google Scholar 

  26. Murtaugh M, Jacobs D, Yu X, Gross M, Steffes M . Correlates of urinary albumin excretion in young blacks and whites: The coronary artery risk development in young adults study. Am J Epidemiol 2003; 158: 676–686.

    Article  PubMed  Google Scholar 

  27. Knight E, Kramer H, Curham G . High normal blood pressure and microalbuminuria. Am J Kidney Dis 2003; 41: 588–595.

    Article  PubMed  Google Scholar 

  28. Hoq S, Chen W, Srinivasan S, Berensen G . Childhood blood pressure predicts adult microalbuminuira in African Americans, but not in whites: the Bogalusa Heart Study. Am J Hypertension 2002; 15: 1036–1041.

    Article  CAS  Google Scholar 

  29. Han T, Sattar N, Williams K, Gonzalez-Villalpando C, Lean M, Haffner S et al. Prospective study of C-reactive protein in relation to the development of diabetes and the metabolic syndrome in the Mexico City diabetes study. Diabetes Care 2002; 25: 2016–2021.

    Article  CAS  PubMed  Google Scholar 

  30. Tamakoshi K, Yatsuya H, Kondo T, Hori Y, Ishikawa M, Zhang H et al. The metabolic syndrome is associated with elevated C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obesity 2003; 27: 443–449.

    Article  CAS  Google Scholar 

  31. Dandona P, Aljada A, Chaudhari A, Mohanty P, Garg R . Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005; 111: 1448–1454.

    Article  PubMed  Google Scholar 

  32. Pearson T, Alexander R, Anderson J, Cannon III RO, Criqui M, Fadl YY et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499–511.

    Article  PubMed  Google Scholar 

  33. Duncan B, Schmidt M, Pankow J, Bang H, Couper D, Ballantyne C et al. Adiponectin and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes 2004; 53: 2473–2478.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant from the Pennsylvania Department of Health. The Department disclaims responsibility for any analyses, interpretations or conclusions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B Falkner.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ussai, K., Keith, S., Pequignot, E. et al. Risk factors associated with urinary albumin excretion in African Americans. J Hum Hypertens 25, 3–10 (2011). https://doi.org/10.1038/jhh.2010.79

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2010.79

Keywords

This article is cited by

Search

Quick links